Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
- 1 January 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 341 (1) , 39-44
- https://doi.org/10.1016/s0014-2999(97)01442-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- THE CANNABINOID RECEPTOR AGONIST WIN 55, 212???2 POTENTLY STIMULATES DOPAMINERGIC NEURONAL ACTIVITY IN THE MESOLIMBIC SYSTEMBehavioural Pharmacology, 1996
- The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathwayBrain Research, 1995
- The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the ratNeuroReport, 1995
- AM630, a competitive cannabinoid receptor antagonistLife Sciences, 1995
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- THC does not affect striatal dopamine release: Microdialysis in freely moving ratsPharmacology Biochemistry and Behavior, 1991
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Δ9-Tetrahydrocannabinol facilitates striatal dopaminergic transmissionPharmacology Biochemistry and Behavior, 1989